WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 7.64 percent. This is a 24 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $8.699 million which missed the analyst consensus estimate of $11.245 million by 22.64 percent. This is a 55.82 percent decrease over sales of $19.692 million the same period last year.